Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Wyeth presents new oxytocin antagonists with potential as tocolytic agents

Nov. 29, 2002

Disappointing preliminary data and negative complete response letter for Replagal

Nov. 29, 2002

Teriparatide more effective than alendronate in postmenopausal osteoporosis

Nov. 29, 2002

Teriparatide approved by the FDA to treat osteoporosis

Nov. 28, 2002

Long-acting, oral DPP-IV inhibitor and hypoglycemic agent presented in Shizuoka

Nov. 28, 2002

Embosphere Microspheres approved for treatment of uterine fibroid

Nov. 28, 2002

European Commission grants marketing authorization for Zavesca

Nov. 27, 2002

Phase I IND cleared for LY-674

Nov. 27, 2002

Preclinical and preliminary clinical data reported for Pyridorin

Nov. 27, 2002

Better antihyperlipidemic profile reported for metformin plus pioglitazone in type 2 diabetes

Nov. 27, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...